|
1
|
Welch DR, Chen P, Miele ME, McGary CT,
Bower JM, Stanbridge EJ, et al: Microcell-mediated transfer of
chromosome 6 into metastatic human C8161 melanoma cells suppresses
metastasis but does not inhibit tumorigenicity. Oncogene.
9:255–262. 1994.
|
|
2
|
Lee JH, Miele ME, Hicks DJ, Phillips KK,
Trent JM, Weissman BE, et al: KiSS-1, a novel human malignant
melanoma metastasis-suppressor gene. J Natl Cancer Inst.
88:1731–1737. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee JH and Welch DR: Identification of
highly expressed genes in metastasis-suppressed chromosome 6/human
malignant melanoma hybrid cells using subtractive hybridization and
differential display. Int J Cancer. 71:1035–1044. 1997. View Article : Google Scholar
|
|
4
|
Lee JH and Welch DR: Suppression of
metastasis in human breast carcinoma MDA-MB-435 cells after
transfection with the metastasis suppressor gene, KiSS-1. Cancer
Res. 57:2384–2387. 1997.PubMed/NCBI
|
|
5
|
Miele ME, Robertson G, Lee JH, Coleman A,
McGary CT, Fisher PB, et al: Metastasis suppressed, but
tumorigenicity and local invasiveness unaffected, in the human
melanoma cell line MelJuSo after introduction of human chromosomes
1 or 6. Mol Carcinog. 15:284–299. 1996. View Article : Google Scholar
|
|
6
|
Miele ME, Jewett MD, Goldberg SF, Hyatt
DL, Morelli C, Gualandi F, et al: A human melanoma
metastasis-suppressor locus maps to 6q16.3-q23. Int J Cancer.
86:524–528. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohtaki T, Shintani Y, Honda S, Matsumoto
H, Hori A, Kanehashi K, et al: Metastasis suppressor gene KiSS-1
encodes peptide ligand of a G-protein-coupled receptor. Nature.
411:613–617. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kotani M, Detheux M, Vandenbogaerde A,
Communi D, Vanderwinden JM, Le Poul E, et al: The metastasis
suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of
the orphan G protein-coupled receptor GPR54. J Biol Chem.
276:34631–34636. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Muir AI, Chamberlain L, Elshourbagy NA,
Michalovich D, Moore DJ, Calamari A, et al: AXOR12, a novel human G
protein-coupled receptor, activated by the peptide KiSS-1. J Biol
Chem. 276:28969–28975. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kirby HR, Maguire JJ, Colledge WH and
Davenport AP: International Union of Basic and Clinical
Pharmacology. LXXVII Kisspeptin receptor nomenclature,
distribution, and function. Pharmacol Rev. 62:565–578. 2010.
View Article : Google Scholar
|
|
11
|
Martin TA, Watkins G and Jiang WG: KiSS-1
expression in human breast cancer. Clin Exp Metastasis. 22:503–511.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Marot D, Bieche I, Aumas C, Esselin S,
Bouquet C, Vacher S, et al: High tumoral levels of Kiss1 and
G-protein-coupled receptor 54 expression are correlated with poor
prognosis of estrogen receptor-positive breast tumors. Endocr Relat
Cancer. 14:691–702. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Prentice LM, Klausen C, Kalloger S, Köbel
M, McKinney S, Santos JL, et al: Kisspeptin and GPR54
immunoreactivity in a cohort of 518 patients defines favourable
prognosis and clear cell subtype in ovarian carcinoma. BMC Med.
5:332007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Masui T, Doi R, Mori T, Toyoda E, Koizumi
M, Kami K, et al: Metastin and its variant forms suppress migration
of pancreatic cancer cells. Biochem Biophys Res Commun. 315:85–92.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nagai K, Doi R, Katagiri F, Ito T, Kida A,
Koizumi M, et al: Prognostic value of metastin expression in human
pancreatic cancer. J Exp Clin Cancer Res. 28:92009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ikeguchi M, Hirooka Y and Kaibara N:
Quantitative reverse transcriptase polymerase chain reaction
analysis for KiSS-1 and orphan G-protein-coupled receptor
(hOT7T175) gene expression in hepatocellular carcinoma. J Cancer
Res Clin Oncol. 129:531–535. 2003. View Article : Google Scholar
|
|
17
|
Shoji S, Tang XY, Umemura S, Itoh J,
Takekoshi S, Shima M, et al: Metastin inhibits migration and
invasion of renal cell carcinoma with overexpression of metastin
receptor. Eur Urol. 55:441–9. 2009. View Article : Google Scholar
|
|
18
|
Hori A, Honda S, Asada M, Ohtaki T, Oda K,
Watanabe T, et al: Metastin suppresses the motility and growth of
CHO cells transfected with its receptor. Biochem Biophys Res
Commun. 286:958–963. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stafford LJ, Xia C, Ma W, Cai Y and Liu M:
Identification and characterization of mouse metastasis-suppressor
KiSS1 and its G-protein-coupled receptor. Cancer Res. 62:5399–5404.
2002.PubMed/NCBI
|
|
20
|
Ramaesh T, Logie JJ, Roseweir AK, Millar
RP, Walker BR, Hadoke PWF, et al: Kisspeptin-10 inhibits
angiogenesis in human placental vessels ex vivo and endothelial
cells in vitro. Endocrinology. 151:5927–5934. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bilban M, Ghaffari-Tabrizi N, Hintermann
E, Bauer S, Molzer S, Zoratti C, et al: Kisspeptin-10, a
KiSS-1/metastin-derived decapeptide, is a physiological invasion
inhibitor of primary human trophoblasts. J Cell Sci. 117:1319–1328.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cho SG, Li D, Stafford LJ, Luo J,
Rodriguez-Villanueva M, Wang Y, et al: KiSS1 suppresses
TNFalpha-induced breast cancer cell invasion via an inhibition of
RhoA-Mediated NF-kappaB activation. J Cell Biochem. 107:1139–1149.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang Y, Berk M, Singh LS, Tan H, Yin L,
Powell CT, et al: KiSS1 suppresses metastasis in human ovarian
cancer via inhibition of protein kinase C alpha. Clin Exp
Metastasis. 22:369–376. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Olbrich T, Ziegler E, Türk G, Schubert A,
Emons G and Gründker C: Kisspeptin-10 inhibits bone-directed
migration of GPR54-positive breast cancer cells: Evidence for a
dose-window effect. Gynecol Oncol. 119:571–578. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Becker JA, Mirjolet JF, Bernard J, Burgeon
E, Simons MJ, Vassart G, et al: Activation of GPR54 promotes cell
cycle arrest and apoptosis of human tumor cells through a specific
transcriptional program not shared by other Gq-coupled receptors.
Biochem Biophys Res Commun. 326:677–686. 2005. View Article : Google Scholar
|
|
26
|
Cho SG, Yi Z, Pang X, Yi T, Wang Y, Luo J,
et al: Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor
angiogenesis by suppressing Sp1-mediated VEGF expression and
FAK/Rho GTPase activation. Cancer Res. 69:7062–7070. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takino T, Koshikawa N, Miyamori H, Tanaka
M, Sasaki T, Okada Y, et al: Cleavage of metastasis suppressor gene
product KiSS-1 protein/metastin by matrix metalloproteinases.
Oncogene. 22:4617–4626. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Harms JF, Welch DR and Miele ME: KISS1
metastasis suppression and emergent pathways. Clin Exp Metastasis.
20:11–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tomita K, Oishi S, Ohno H, Peiper SC and
Fujii N: Development of novel G-protein-coupled receptor 54
agonists with resistance to degradation by matrix
metalloproteinase. J Med Chem. 51:7645–7649. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pampillo M, Camuso N, Taylor JE,
Szereszewski JM, Ahow MR, Zajac M, et al: Regulation of GPR54
signaling by GRK2 and beta-arrestin. Mol Endocrinol. 23:2060–2074.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nash KT, Phadke PA, Navenot JM, Hurst DR,
Accavitti-Loper MA, Sztul E, et al: Requirement of KISS1 secretion
for multiple organ metastasis suppression and maintenance of tumor
dormancy. J Natl Cancer Inst. 99:309–321. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mikkelsen JD, Bentsen AH, Ansel L,
Simonneaux V and Juul A: Comparison of the effects of peripherally
administered kisspeptins. Regul Pept. 152:95–100. 2009. View Article : Google Scholar : PubMed/NCBI
|
